Sign In
Buy REPL
$13.67
+1.61 (+13.35%)
At Close: Aug 10, 2026
Replimune Group (NASDAQ:REPL) Shares Gap Up on Analyst Upgrade
01:21am, Tuesday, 11'th Aug 2026
Replimune Group, Inc. (NASDAQ: REPL - Get Free Report)'s stock price gapped up before the market opened on Monday after JPMorgan Chase and Co. raised their price target on the stock from $17.00 to $20
NEW YORK--(BUSINESS WIRE)---- $REPL #ClassAction--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Replimune Group, Inc. (�
SAN DIEGO, Aug. 10, 2026 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Replimune Group, Inc. (NASDAQ: REPL) securities between October 20, 2025 and April
Here's Why Replimune Stock Skyrockets Nearly 223% in 3 Months
11:21am, Monday, 10'th Aug 2026
REPL's RP1 secures FDA approval for advanced melanoma, easing regulatory uncertainty. The company expands its oncolytic immunotherapy pipeline.
SAN DIEGO, Aug. 10, 2026 /PRNewswire/ -- Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acqu
Replimune Group, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights -- REPL
08:00am, Monday, 10'th Aug 2026
[url="]The DJS Law Group[/url] reminds investors of a class action lawsuit against Replimune Group, Inc. (âReplimuneâ or âthe Companyâ) (NASDAQ: [url="]
Replimune Announces Pricing of $150 Million Underwritten Offering
08:00am, Monday, 10'th Aug 2026
BOSTON, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL) (“Replimune”), a commercial-stage biotechnology company pioneering the development of novel oncolytic immunotherapies
Replimune Group, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – REPL
07:30am, Monday, 10'th Aug 2026
LOS ANGELES--(BUSINESS WIRE)---- $REPL--Replimune Group, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – REPL.
REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Fraud Lawsuit with SBS Law
05:07pm, Friday, 07'th Aug 2026
LOS ANGELES--(BUSINESS WIRE)---- $REPL--REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Fraud Lawsuit with SBS Law.
[url="]The Law Offices of Frank R. Cruz[/url] reminds investors of the upcoming October 5, 2026 deadline to participate as a lead plaintiff in the securities fr
[url="]Glancy Prongay Wolke and Rotter LLP[/url] reminds investors of the upcoming October 5, 2026 deadline to file a lead plaintiff motion in the class action fi
Deadline Approaching: Replimune Group, Inc. (REPL) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
03:00pm, Friday, 07'th Aug 2026
Law Offices of Howard G. Smith reminds investors of the upcoming October 5, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investo
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming October 5, 2026 deadline to participate as a lead plaintiff in the securities fraud class action lawsui
Deadline Approaching: Replimune Group, Inc. (REPL) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
02:39pm, Friday, 07'th Aug 2026
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming October 5, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who p
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming October 5, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of invest
